Works matching IS 13479032 AND DT 2008 AND VI 99 AND IP 1


Results: 27
    1
    2
    3
    4
    5
    6

    Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma.

    Published in:
    Cancer Science, 2008, v. 99, n. 1, p. 140, doi. 10.1111/j.1349-7006.2007.00638.x
    By:
    • Ogawa, Yoshiaki;
    • Tobinai, Kensei;
    • Ogura, Michinori;
    • Ando, Kiyoshi;
    • Tsuchiya, Takahide;
    • Kobayashi, Yukio;
    • Watanabe, Takashi;
    • Maruyama, Dai;
    • Morishima, Yasuo;
    • Kagami, Yoshitoyo;
    • Taji, Hirofumi;
    • Minami, Hironobu;
    • Itoh, Kuniaki;
    • Nakata, Masanobu;
    • Hotta, Tomomitsu
    Publication type:
    Article
    7

    Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.

    Published in:
    Cancer Science, 2008, v. 99, n. 1, p. 145, doi. 10.1111/j.1349-7006.2007.00639.x
    By:
    • Tokuda, Yutaka;
    • Tajima, Tomoo;
    • Narabayashi, Masaru;
    • Takeyama, Kunihiko;
    • Watanabe, Toru;
    • Fukutomi, Takashi;
    • Chou, Takaaki;
    • Sano, Muneaki;
    • Igarashi, Tadahiko;
    • Sasaki, Yasutsuna;
    • Ogura, Michinori;
    • Miura, Shigeto;
    • Okamoto, Shin-ichiro;
    • Ogita, Masami;
    • Kasai, Masaharu;
    • Kobayashi, Tadashi;
    • Fukuda, Haruhiko;
    • Takashima, Shigemitsu;
    • Tobinai, Kensei
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Correction.

    Published in:
    2008
    Publication type:
    Correction Notice
    25
    26
    27